Trial intelligence / Profile preview

Acetylcysteine plus High-dose Dexamethasone in Newly-diagnosed ITP

NCT04368598Phase 2Unknown

Sponsor
Peking University People's Hospital
Start
Apr 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.

02

Drugs

acetylcysteine
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT04368598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04368598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call